These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8943855)

  • 1. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients.
    Lensen RP; Rosendaal FR; Koster T; Allaart CF; de Ronde H; Vandenbroucke JP; Reitsma PH; Bertina RM
    Blood; 1996 Dec; 88(11):4205-8. PubMed ID: 8943855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
    Martinelli I; Mannucci PM; De Stefano V; Taioli E; Rossi V; Crosti F; Paciaroni K; Leone G; Faioni EM
    Blood; 1998 Oct; 92(7):2353-8. PubMed ID: 9746774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
    Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
    Castaman G; Tosetto A; Ruggeri M; Rodeghiero F
    Br J Haematol; 1999 Jul; 106(1):232-6. PubMed ID: 10444192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.
    Koeleman BP; Reitsma PH; Allaart CF; Bertina RM
    Blood; 1994 Aug; 84(4):1031-5. PubMed ID: 8049422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency.
    Zehnder JL; Jain M
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):361-2. PubMed ID: 8735145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
    Brenner B; Zivelin A; Lanir N; Greengard JS; Griffin JH; Seligsohn U
    Blood; 1996 Aug; 88(3):877-80. PubMed ID: 8704244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of factor V deficiency with factor V HR2.
    Faioni EM; Castaman G; Asti D; Lussana F; Rodeghiero F
    Haematologica; 2004 Feb; 89(2):195-200. PubMed ID: 15003895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
    Zöller B; Norlund L; Leksell H; Nilsson JE; von Schenck H; Rosén U; Jepsson JO; Dahlbäck B
    Thromb Res; 1996 Sep; 83(6):475-7. PubMed ID: 8885142
    [No Abstract]   [Full Text] [Related]  

  • 15. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
    Faioni EM; Razzari C; Martinelli I; Panzeri D; Franchi F; Mannucci PM
    Am J Hematol; 1997 Jun; 55(2):59-64. PubMed ID: 9208999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An underestimated combination of opposites resulting in enhanced thrombotic tendency.
    Simioni P; Castoldi E; Lunghi B; Tormene D; Rosing J; Bernardi F
    Blood; 2005 Oct; 106(7):2363-5. PubMed ID: 15961511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study.
    Nowak-Göttl U; Dübbers A; Kececioglu D; Koch HG; Kotthoff S; Runde J; Vielhaber H
    J Pediatr; 1997 Oct; 131(4):608-12. PubMed ID: 9386668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.